TENORMINE 5 mg/10 ml, solution for injection IV in an ampoule 5 ampoules of 10 ml
Active ingredients: Atenolol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injection5 ampoules of 10 mlintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- TENORMINE 5 mg/10 ml, solution injectable IV en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 1987
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61436304CIP73274838CIP133400932748389Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATÉNOLOLsolution | 5 mg · une ampoule de 10 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.